Many scientists believed a single, effective treatment for all patients wouldn't be possible, instead focusing on genetic forms of disease, but AcuraStem is showing how it can be done.
News & Events
Join AcuraStem's CEO, Sam Alworth, at the forthcoming 2023 BIO International Convention in Boston from June 5-8, 2023. AcuraStem is at the cutting edge of developing treatments for neurodegenerative diseases, including sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
Dr. Wen-Hsuan Chang, AcuraStem’s Head of Target Validation to present at the 33rd International Symposium on ALS/MND
Dr. Wen-Hsuan Chang, AcuraStem’s Head of Target Validation to present at the 33nd International Symposium on ALS/MND being held virtually on December 6-9, 2022. Dr. Chang will detail AcuraStem’s development program leveraging its best-in-class iNeuroRx® platform, composed of patient-derived disease models that accurately recapitulate UNC13A pathology, to develop novel and potent UNC13A antisense oligonucleotide (ASO) drug candidates. UNC13A is one of the most significant genetic risk factors for ALS and FTD.
Team AcuraStem is honored to continue its partnership with Team Nanci and the ALS Association Golden West Chapter in the fight against ALS as a sponsor of the Greater Los Angeles Walk to Defeat ALS® on Sunday, November 6, at Exposition Park in Los Angeles.
Scientific Cofounder, Dr. Justin K. Ichida, and Head of Research, Dr. Wen-Hsuan Chang to present at the 32nd International Symposium on ALS/MND, being held virtually on December 7-10, 2021
AcuraStem will present posters at the 32nd International Symposium on ALS/MND.
AcuraStem CEO to Present at Translational Solutions’ Virtual Investor and Innovator Conference on Accelerating Innovations and Investments in Rare and Orphan Diseases in Partnership with the Keiretsu Forum Canada and Episome
Sam Alworth, has been invited to present at Translational Solutions’ Virtual Investor...
AcuraStem Team Participates as Mentor Sponsors at the 10th Annual ALS Research Summit in Los Angeles, CA
The California ALS Research Summit held on Jan 24-25, 2020 was the tenth annual gathering of researchers, investigators, clinicians, biotech companies, government representatives, partner organizations, and advocates in ALS and related fields in the State of California. AcuraStem was proud to be on hand as mentor sponsors.
October 26th, 2019, UCLA California NanoSystems Institute: CEO, Co-Founder Sam Alworth Presenting at the 5th Annual BCLA Biotech Summit "Mapping out LA’s Biotech Landscape"
Academy Award-winning actress Renee Zellweger encourages the audience to learn more about AcuraStem’s research work in amyotrophic lateral sclerosis (ALS) at the 16th Annual ALS Association Walk to Defeat ALS at Exposition Park in Los Angeles
AcuraStem Joins Team Nanci and The ALS Association Golden West Chapter at LA Walk to Defeat ALS Sunday, Nov. 4
AcuraStem will join in the fight against ALS as a sponsor of the 16th Annual Los Angeles County Walk to Defeat ALS® on Sunday, November 4, at Exposition Park in Los Angeles. The team will walk with “Team Nanci” and be on hand at the AcuraStem booth to talk to patients and families affected by Amyotrophic Lateral Sclerosis (ALS) about its mission and research underway.
AcuraStem is pleased to announce that it has been selected as a finalist in the 2018 Start-Up Stadium event at the BIO International Convention, June 4-7 in Boston.
This two-day event, which immediately precedes Rare Disease Day on February 28, 2018, will be held at the Icagen Oro Valley location (North of Tucson). The Symposium will feature presentations from a mix of academic and industry speakers from the pharmaceutical and biotechnology communities as well as key opinion leaders from foundations committed to the identification, treatment, and cure of rare diseases.
The award recognizes Dr. Ichida's "pioneering work to convert patients’ skin cells into disease-affected neural cells, enabling them to screen thousands of drug-like compounds in search of potential therapeutics that could slow or stop ALS."